Articoli con mandati relativi all'accesso pubblico - Diana Torres (ORCID: 0000-0002-9879-9775)Ulteriori informazioni
Non disponibile pubblicamente: 1
Controlla
The CYP17A1− 34T> C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers
B Kaufman, Y Laitman, E Ziv, U Hamann, D Torres, EL Lahad, R Beeri, ...
Breast cancer research and treatment 126 (2), 521-527, 2011
Mandati: Canadian Institutes of Health Research, Cancer Research UK
Disponibili pubblicamente: 73
Controlla
Association analysis identifies 65 new breast cancer risk loci
K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ...
Nature 551 (7678), 92-94, 2017
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Controlla
Breast Cancer Risk Genes-Association Analysis in More than 113,000 Women.
L Dorling, S Carvalho, J Allen, A González-Neira, C Luccarini, ...
The New England journal of medicine 384 (5), 428-439, 2021
Mandati: Cancer Research UK, UK Medical Research Council, Wellcome Trust, European …
Controlla
Prediction of breast cancer risk based on profiling with common genetic variants
N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ...
JNCI: Journal of the National Cancer Institute 107 (5), 2015
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
A common coding variant in CASP8 is associated with breast cancer risk
A Cox, AM Dunning, M Garcia-Closas, S Balasubramanian, MWR Reed, ...
Nature genetics 39 (3), 352-358, 2007
Mandati: German Research Foundation
Controlla
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
K Michailidou, J Beesley, S Lindstrom, S Canisius, J Dennis, MJ Lush, ...
Nature genetics 47 (4), 373-380, 2015
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Controlla
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ...
Jama 313 (13), 1347-1361, 2015
Mandati: US National Institutes of Health, Cancer Research UK, National Institute for …
Controlla
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ...
Nature genetics 49 (12), 1767-1778, 2017
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
H Zhang, TU Ahearn, J Lecarpentier, D Barnes, J Beesley, G Qi, X Jiang, ...
Nature genetics 52 (6), 572-581, 2020
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ...
Human mutation 39 (5), 593-620, 2018
Mandati: US Department of Defense, US National Institutes of Health, National Health …
Controlla
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure …
O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ...
European journal of heart failure 21 (11), 1338-1352, 2019
Mandati: Ministry of Education, Science and Technological Development of the Republic …
Controlla
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ...
Journal of medical genetics 53 (12), 800-811, 2016
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
L Wu, W Shi, J Long, X Guo, K Michailidou, J Beesley, MK Bolla, XO Shu, ...
Nature genetics 50 (7), 968-978, 2018
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Controlla
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
KS Purrington, S Slager, D Eccles, D Yannoukakos, PA Fasching, P Miron, ...
Carcinogenesis 35 (5), 1012-1019, 2014
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
Cancer risks associated with BRCA1 and BRCA2 pathogenic variants
S Li, V Silvestri, G Leslie, TR Rebbeck, SL Neuhausen, JL Hopper, ...
Journal of Clinical Oncology 40 (14), 1529, 2022
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ...
Nature genetics 52 (1), 56-73, 2020
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Controlla
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
AM Dunning, K Michailidou, KB Kuchenbaecker, D Thompson, JD French, ...
Nature genetics 48 (4), 374-386, 2016
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Controlla
Height and breast cancer risk: evidence from prospective studies and Mendelian randomization
B Zhang, XO Shu, RJ Delahanty, C Zeng, K Michailidou, MK Bolla, ...
Journal of the National Cancer Institute 107 (11), djv219, 2015
Mandati: US National Institutes of Health, National Health and Medical Research …
Controlla
Genetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of European descent
Y Guo, S Warren Andersen, XO Shu, K Michailidou, MK Bolla, Q Wang, ...
PLoS medicine 13 (8), e1002105, 2016
Mandati: US National Institutes of Health, Cancer Research UK
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software